Studies Directed Toward the Synthesis of Taxanes
FULL PAPER
1
Ϫ H NMR (CDCl3): δ ϭ 0.97 (s, 3 H), 1.06 (s, 3 H), 1.42Ϫ2.22 General Procedure for the Preparation of Nitro Compounds 16a؊c
(m, 9 H), 2.84 (d, J ϭ 6.0 Hz, 2 Hsyn,), 3.05 (d, J ϭ 5.1 Hz, 2 Hanti),
4.92 (d, J ϭ 10.1 Hz, 1 H), 5.02 (d, J ϭ 17.1 Hz, 1 H), 5.32 (t, J ϭ
3.0 Hz, 1 Hsyn), 5.38 (t, J ϭ 3.0 Hz, 1 Hanti), 5.76Ϫ5.90 (m, 1 H),
6.69 (t, J ϭ 5.1 Hz, 1 Hanti), 7.37 (t, J ϭ 6.0 Hz, 1 Hsyn), 9.28
(broad s, 1 H, OHanti), 9.72 (broad s, 1 H, OHsyn). Ϫ 13C NMR
(CDCl3): δ ϭ 21.82, 22.00, 22.72, 26.92, 27.69, 31.84, 33.34, 42.65,
74.73, 114.17, 122.76 (syn), 123.25 (anti), 138.98, 139.17, 151.03
From the Corresponding Iodides.
Nitro Compound 16a: A solution of iodide 15a (1.4 g, 3.74 mmol) in
DMF (100 mL) was added to a mixture of sodium nitrite (577 mg,
8.36 mmol) and urea (638 mg, 10.5 mmol) in DMF (50 mL). After
vigorously stirring for 6 h at Ϫ78°C in the dark ether (150 mL) and
water (250 mL) were added. The organic layer was separated and
the aqueous phase extracted with ether (4 ϫ 150 mL). The com-
bined organic phases were successively washed with water
(2 ϫ 100 mL), 20% aqueous sodium thiosulfate (100 mL) and brine
(100 mL), and then dried over magnesium sulfate. After filtration
and concentration in vacuo, chromatography on silica gel (pentane/
ether, 2:1), afforded 489 mg (45%) of 16a. Ϫ 1H NMR (CDCl3):
δ ϭ 1.01 (s, 3 H), 1.08 (s, 3 H), 1.21Ϫ2.32 (m, 13 H), 2.31 (m, 1
H), 2.66 (t, J ϭ 7.4 Hz, 2 H), 4.48 (t, J ϭ 7.4 Hz, 2 H), 5.32 (s,1
H), 5.47 (dd, J ϭ 1.7, 9.8 Hz, 1 Hmajor), 5.61Ϫ5.73 (m, 1 H), 5.90
(dd, J ϭ 1.9, 9.5 Hz, 1 Hminor). Ϫ 13C NMR (CDCl3): δ ϭ 21.14,
21.87, 22.20, 22.65, 24.85, 27.37, 29.05, 30.60 (minor), 30.75
(major), 30.92 (major), 31.39 (minor), 40.44 (major), 40.64 (minor),
43.03, 74.86, 75.04, 122.03, 126.34 (minor), 126.75 (major), 133.28,
138.25. Ϫ MS (CI, NH3); m/z (%): 311 (100) [Mϩ ϩ NH4].
(anti), 151.51 (syn). Ϫ MS (CI, NH3); m/z (%): 220 (16) [Mϩ
Ϫ
OH], 238 (56) [Mϩ ϩ H], 255 (100) [Mϩ ϩ NH4]. Ϫ C14H23NO2
[Mϩ]: calcd. 237.1729; found 237.1725 (HRMS).
General Procedure for the Preparation of Iodides 15a؊c From the
Corresponding Alcohols.
Iodide 15a: Iodine (290 mg, 1.14 mmol) was added portionwise to a
solution of triphenylphosphane (299 mg, 1.14 mmol) and imidazole
(77 mg, 1.14 mmol) in ether/acetonitrile (4:1, 5 mL) at 0°C. After
vigorously stirring for 20 min at 0°C, the reaction mixture was
stirred for 20 min at room temperature, then cooled to 0°C. A solu-
tion of diol 12a (100 mg, 0.38 mmol) in ether/acetonitrile (4:1,
2 mL) was added dropwise over 10 min. The reaction mixture was
vigorously stirred for 4 h at room temperature, and then filtered.
The solid residue was washed with ether (20 mL), and the filtrate
concentrated in vacuo. Ether (40 mL) was added, and the organic
phase successively washed with brine (10 mL), saturated aqueous
NaHCO3 (3 ϫ 10 mL) and brine (10 mL), then dried over mag-
nesium sulfate. After filtration and concentration in vacuo, chro-
matography on silica gel (pentane/AcOEt, 95:5), afforded 122 mg
(86%) of iodide 15a. Ϫ IR (film): ν˜ ϭ 3261 (broad, OH), 2924,
Nitro Compound 16b: Prepared as described above from iodide 15b
(805 mg, 2.41 mmol). Chromatography on silica gel (pentane/Ac-
OEt, 97:3), afforded 352 mg (58%) of 16b. Ϫ IR (film): ν˜ ϭ 3451
(broad, OH), 2956, 1640 (CϭC), 1554, 1473, 1447, 1380 cmϪ1. Ϫ
1H NMR (CDCl3): δ ϭ 1.02 (s, 3 H), 1.10 (s, 3 H), 1.38 (s, 1H,
OH), 1.50Ϫ2.10 (m, 8 H), 2.68 (t, J ϭ 7.2 Hz, 2 H), 4.48 (t, J ϭ
7.2 Hz, 2 H), 4.95 (d, J ϭ 9.8 Hz, 1 H), 5.04 (d, J ϭ 17.1 Hz, 1 H),
5.32 (t, J ϭ 3.0 Hz, 1 H), 5.78Ϫ5.84 (m, 1 H). Ϫ 13C NMR
(CDCl3): δ ϭ 21.87, 22.13, 22.65, 26.85, 27.89, 28.92, 33.27, 42.71,
74.34, 74.81, 114.29, 122.03, 138.26, 139.11. Ϫ MS (CI, NH3); m/z
(%): 271 (100) [Mϩ ϩ NH4]. Ϫ C13H20NO3 [Mϩ Ϫ CH3]: calcd.
238.1443; found 238.1464 (HRMS).
1
1650 (CϭC), 1170 cmϪ1. Ϫ H NMR (CDCl3): δ ϭ 0.97 (s, 3 H),
1.05 (s, 3 H), 1.18Ϫ2.10 (m, 13 H), 2.33Ϫ2.45 (m, 1 H), 2.56 (t,
J ϭ 7.9 Hz, 2 H), 3.21 (t, J ϭ 7.9 Hz, 2 H), 5.38 (s,1 H), 5.49 (dd,
J ϭ 1.7, 9.8 Hz, 1 Hmajor), 5.60Ϫ5.65 (m, 1 H), 5.91 (dd, J ϭ 1.8,
9.8 Hz, 1 Hminor). Ϫ 13C NMR (CDCl3): δ ϭ 5.05, 21.18, 21.91,
22.40, 22.58, 24.86, 27.31, 30.60 (minor), 30.74 (major), 30.94
(major), 31.40 (minor), 36.50, 40.42 (major), 40.62 (minor), 42.89,
75.18, 121.63, 126.22 (minor), 126.66 (major), 132.88 (minor),
Nitro Compound 16c: Prepared as described above from iodide 15c
(91.7 mg, 0.31 mmol). The crude product was chromatographed on
silica gel; elution with pentane/ether (85:15) afforded 9.5 mg (14%)
of nitrito compound, then elution with pentane/ether (60:40) af-
forded 42 mg (61%) of 16c. Ϫ IR (film): ν˜ ϭ 3480 (broad, OH),
3580, 3480, 3074, 2975, 2950, 2900, 2850, 1640, 1550, 1471, 1443,
1381, 1194, 1078, 1003 cmϪ1. Ϫ 1H NMR (CDCl3): δ ϭ 5.93 (ddt,
J ϭ 17.4, 10.2, 7.5, 6.6 Hz, 1 H), 5.33 (t, J ϭ 3.6 Hz, 1 H), 5.15
(d, J ϭ 10.2 Hz, 1 H), 5.12 (d, J ϭ 17.4 Hz, 1 H), 4.49 (t, J ϭ
7.5 Hz, 2 H), 2.7 (td, J ϭ 7.5, 1.5 Hz, 2 H), 2.32 (dd, J ϭ 6.6,
14.1 Hz, 1 H), 2.15 (dd, J ϭ 7.5, 14.1 Hz, 1 H), 2.05 (m, 2 H), 1.7
(m, 1 H), 1.6 (m, 1 H), 1.25 (broad s, 1 H, OH), 1.04 (s, 3 H), 1.11
(s, 3 H). Ϫ 13C NMR (CDCl3): δ ϭ 138, 134.7, 122, 118.5, 74.8,
74, 42.3, 38.9, 28.9, 27.7, 22.5, 21.8, 22.3. Ϫ MS (CI, NH3); m/z
(%): 222 (78) [Mϩ Ϫ OH], 257 (100) [Mϩ ϩ NH4]. Ϫ C10H16NO3
[Mϩ Ϫ CH2CHϭCH2]: calcd. 198.1130; found 198.1143 (HRMS).
133.45 (major), 142.98. Ϫ MS (CI, NH3); m/z (%): 357 (7) [Mϩ
OH], 392 (100) [Mϩ ϩ NH4].
Ϫ
Iodide 15b: Prepared as described above from diol 12b (500 mg,
2.23 mmol). Chromatography on silica gel (pentane/AcOEt, 95:5),
afforded 700 mg (94%) of iodide 15b. Ϫ IR (film): ν˜ ϭ 3397 (broad,
OH), 2954, 1639 (CϭC), 1470, 1446, 1168, 1032 cmϪ1. Ϫ 1H NMR
(CDCl3): δ ϭ 0.99 (s, 3 H), 1.07 (s, 3 H), 1.36 (s, 1 H, OH),
1.45Ϫ2.30 (m, 8 H), 2.53 (t, J ϭ 8.0 Hz, 2 H), 3.22 (t, J ϭ 8.0 Hz,
2 H), 4.95 (d, J ϭ 11.0 Hz, 1 H), 5.08 (d, J ϭ 17.1 Hz, 1 H), 5.38
(s, 1 H), 5.80Ϫ5.93 (m, 1 H). Ϫ 13C NMR (CDCl3): δ ϭ 4.92,
21.91, 22.07, 22.65, 27.04, 27.89, 33.33, 36.44, 42.58, 74.41, 114.14,
121.64, 139.25, 142.98. Ϫ MS (CI, NH3); m/z (%): 317 (27) [Mϩ
Ϫ
OH], 352 (100) [Mϩ ϩ NH4]. Ϫ C14H23O [Mϩ Ϫ I]: calcd.
Nitrito Compound. Ϫ 1H NMR (CDCl3): δ ϭ 5.96 (dddd, J ϭ 16.8,
10.2, 7.8, 6.9 Hz, 1 H), 5.4 (t, J ϭ 3.6 Hz, 1 H), 5.15 (d, J ϭ
10.2 Hz, 1 H), 5.12 (d, J ϭ 16.8 Hz, 1 H), 4.8 (t, J ϭ 7.2 Hz, 2 H),
2.39 (t, J ϭ 7.2 Hz, 2 H), 2.3 (dd, J ϭ 6.9, 13.8 Hz, 1 H), 2.2 (dd,
J ϭ 7.8, 13.8 Hz, 1 H), 2.05 (m, 2 H), 1.7 (m, 1 H), 1.6 (m, 1 H),
1.02 and 1.10 (2s, 6 H). Ϫ 13C NMR (CDCl3): δ ϭ 134.5, 122.0,
118.5, 75.0, 68.0, 42.0, 39.0, 27.8, 25.0, 22.5, 22.2, 22.0.
207.1749; found 207.1746 (HRMS).
Iodide 15c: Prepared as described above from diol 12c (246 mg,
1.17 mmol). Chromatography on silica gel (pentane/ether, 4:6), af-
forded 370 mg (99%) of iodide 15c. Ϫ IR (film): ν˜ ϭ 3580 (broad,
OH), 3460, 3075, 2980, 1638, 1470, 1440, 1360, 1170 cmϪ1. Ϫ H
1
NMR (CDCl3): δ ϭ 5.85 (dddd, J ϭ 17.1, 10.2, 8.4, 6.6 Hz, 1 H),
5.3 (t, J ϭ 3.6 Hz, 1 H), 5.06 (d, J ϭ 10.2 Hz, 1 H), 5.03 (d, J ϭ
17.1 Hz, 1 H), 3.15 (t, J ϭ 8.1 Hz, 2 H), 2.45 (t, J ϭ 8.1 Hz, 2 H), Isoxazoline 19: A solution of oxime 14b (22.3 mg, 0.094 mmol) was
2.25 (dd, J ϭ 14.1, 6.6 Hz, 1 H), 2.11 (dd, J ϭ 14, 8.4 Hz, 1 H), added in 1 h (with a syringe pump) to a vigorously stirred mixture
1.9Ϫ2.0 (m, 2 H), 1.6 (m, 1 H), 1.5 (m, 1 H), 0.93 (s, 3 H), 1.0 (s, of dichloromethane (50 mL), sodium hypochlorite (0.75 mL,
3 H). Ϫ 13C NMR (CDCl3): δ ϭ 142.9, 134.6, 121.8, 118.2, 74.1, 1.88 mmol, 2.5 in water) and 40% aqueous tetrabutylammonium
42.1, 38.9, 36.3, 27.8, 22.4, 21.9, 5.0. Ϫ MS (CI, NH3); m/z (%):
303 (28) [Mϩ Ϫ OH], 338 (100) [Mϩ ϩ NH4].
hydroxide solution (1 drop). After stirring for 30 min at room tem-
perature, the organic phase was washed with water (2 ϫ 15 mL)
Eur. J. Org. Chem. 1999, 3241Ϫ3249
3247